Maltotriose-modified poly(propylene imine) Glycodendrimers as a potential novel platform in the treatment of chronic lymphocytic Leukemia. A proof-of-concept pilot study in the animal model of CLL.
暂无分享,去创建一个
M. Borowiec | M. Danilewicz | D. Appelhans | M. Bryszewska | I. Franiak-Pietryga | B. Ziemba | H. Sikorska | Magdalena Jander | P. Lewkowicz | K. Ostrowska | Wojciech Kuncman